Compare · OST vs TMO
OST vs TMO
Side-by-side comparison of Ostin Technology Group Co. Ltd. (OST) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- OST operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
- TMO carries a market cap of $225.41B.
- Over the past year, OST is down 97.7% and TMO is up 11.5% - TMO leads by 109.1 points.
- TMO has hit the wire 6 times in the past 4 weeks while OST has been quiet.
- TMO has more recent analyst coverage (25 ratings vs 0 for OST).
- Company
- Ostin Technology Group Co. Ltd.
- Thermo Fisher Scientific Inc
- Price
- $1.72+0.29%
- $469.57+0.63%
- Market cap
- -
- $225.41B
- 1M return
- +0.00%
- -4.31%
- 1Y return
- -97.68%
- +11.45%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- News (4w)
- 0
- 6
- Recent ratings
- 0
- 25
Ostin Technology Group Co. Ltd.
Ostin Technology Group Co., Ltd. designs, develops, and manufactures thin-film transistor liquid crystal display (TFT-LCD) modules and polarizers in China. The company offers TFT-LCD solutions for drive IC, TCON board, and power supply applications; back light systems and special modules; LC display modules, touch panel modules, and smart display terminals; and polarizers used in the TFT-LCD display modules. It offers display modules to markets, such as consumer electronics, including AIOs, monitors, laptop computers, and tablets; automotive displays, including dashboard, and navigation and multimedia systems; and outdoor LCD displays, which are used to display multimedia graphics, such as company advertisements, promotions, scoreboards, and traffic signs. The company sells its products directly to customers, as well as to customers' designated system integrators. Ostin Technology Group Co., Ltd. was founded in 2010 and is based in Nanjing, China with manufacturing facilities in China.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest OST
- SEC Form 3 filed by new insider Cui Rongguo
- SEC Form 3 filed by new insider Yin Xiao Hong
- SEC Form 3 filed by new insider Mein John Carl
- SEC Form 6-K filed by Ostin Technology Group Co. Ltd.
- SEC Form 20-F filed by Ostin Technology Group Co. Ltd.
- SEC Form 6-K filed by Ostin Technology Group Co. Ltd.
- Mass Production Ignition Ceremony for Colorless Transparent Polyimide Thin Film Production Line of SAEM For Ostin Group
- SEC Form 6-K filed by Ostin Technology Group Co. Ltd.
- SEC Form 6-K filed by Ostin Technology Group Co. Ltd.
- SEC Form 6-K filed by Ostin Technology Group Co. Ltd.
Latest TMO
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Thermo Fisher Scientific Reports First Quarter 2026 Results
- AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
- Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale Proteomics
- SEC Form DEFA14A filed by Thermo Fisher Scientific Inc
- SEC Form DEF 14A filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026
- SEC Form 4 filed by Sperling Scott M
- SEC Form 4 filed by Keith R. Alexandra
- SEC Form 4 filed by Lynch Karen S